Navigation Links
Neuralstem Reports First Quarter Financial Results And Provides Business And Clinical Update
Date:5/10/2013

es authorized, zero shares issued and outstanding

--Common stock, $0.01 par value; 150 million shares authorized, 68,797,964 and
68,189,314 shares outstanding in 2013 and 2012, respectively

687,980681,893Additional paid-in capital

117,190,135114,884,915Accumulated deficit

(112,184,262)(108,594,175)Total stockholders' equity5,693,8536,972,633Total liabilities and stockholders' equity$
5,411,397$
8,750,079 

 Neuralstem, Inc.Unaudited Condensed Statements of OperationsThree Months Ended March 31,20132012Revenues

$
2,500$
56,250Operating expenses:Research and development costs

1,748,3471,422,364General and administrative expenses

1,195,8401,162,156Depreciation and amortization

50,09334,946Total operating expenses

2,994,2802,619,466Operating loss

(2,891,780)(2,463,216)Other income (expense):Interest income

9,9258,715Interest expense

(48,257)(853)Warrant modification expense

(666,736)-Gain from change in fair value of derivative instruments

6,518-Other income

2432,573Total other income (expense) 

(698,307)10,435Net loss

$
(3,590,087)$
(2,452,781)Net loss per share - basic and diluted

$
(0.05)$
(0.05)Weighted average common shares outstanding - basic and diluted

68,700,70951,433,217 


'/>"/>
SOURCE Neuralstem, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Neuralstem Announces 2012 Financial Results, Provides Clinical Trials Update
2. Neuralstem Cells Induce Significant Functional Improvement In Permanent Rat Spinal Cord Injury, Cell Study Reports
3. Neuralstem President And CEO To Present At The 2012 Rodman & Renshaw Annual Healthcare Conference
4. Neuralstem Receives Notice Of Issuance For Patent Covering Human Neural Cell Transplantation For Neurodegenerative Conditions
5. Neuralstem CEO to Present at the World Stem Cells and Regenerative Medicine Congress in London
6. Fourteenth Patient Dosed in Neuralstem ALS Stem Cell Trial
7. Neuralstem Announces Closing of $5.2-Million Registered Direct Offering
8. Neuralstem President and CEO to Present at BIO CEO & Investor Conference 2012
9. Neuralstem President and CEO to Update Ongoing ALS and NSI-189/Major Depressive Disorder Trials at 2012 Biotech Showcase
10. Neuralstem ALS Stem Cell Trial Featured on Fox Atlanta
11. Inovio Pharmaceuticals Reports 2013 First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2015)... As a symbol of its commitment to ... manufacturing clients, Whitehouse Laboratories is excited to announce that ... Team for the 2015 race season. Success on the ... strong sense of precision and attention to detail. These ... the quality control testing laboratory. Sponsorship of the race ...
(Date:3/27/2015)... YORK , March 27, 2015   ... in liquid photopurification, announced today that the Company ... for the continued trading of SurePure ("SURP") securities ... venture marketplace for entrepreneurial and development stage companies. ... Group introduced standards and eligibility requirements designed to ...
(Date:3/27/2015)... Governor Andrew M. Cuomo today announced ... - the world’s largest business idea competition with $5 ... $1 million, six $500,000 awards and four $250,000 awards. ... compete for prizes that will turn ideas with high ... York region. , "Last year's successful 43North competition ...
(Date:3/26/2015)... March 26, 2015  BioNano Genomics, Inc., the leader ... Salyer as chief commercial officer. Salyer has more ... sales teams in life sciences. At BioNano, Salyer will ... a genome-mapping platform to assemble a comprehensive view of ... To date, 32 institutions located in the ...
Breaking Biology Technology:Whitehouse Laboratories Reaffirms Commitment to Speedy Results – Renews Sponsorship of Berkenstock Racing Team 2SurePure Completes Verification and Approved for Trading on the OTCQB Marketplace 2Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 2Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 3Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 4Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 5BioNano Genomics Appoints Terry Salyer as Chief Commercial Officer 2BioNano Genomics Appoints Terry Salyer as Chief Commercial Officer 3
... , , , , , , ... PCR clean up system capable , of purifying amplicons as small ... simple, three-step protocol requiring no centrifugation , or filtration steps. The ... 96 and 384-well formats. , , ...
... , , , The primary requirements ... at temperatures around 75C and the ability to retain that activity , ... single DNA polymerases were used in PCR, where Taq , ... combined RT-PCR, and Pwo , ...
... , , , , , Kit for PCR and PCR carry-over , ... , , , Catalog Number, ... 1585541, 1 kit (50 PCR and UNG reactions), ... Special Interest Sites , , Innovative , ...
Cached Biology Technology:AMPURE PURIFICATION SYSTEM 2AMPURE PURIFICATION SYSTEM 3
(Date:3/12/2015)... BERLIN , March 12, 2015 ... IAM, a standardized identity and access management (IAM) ... reliable implementation schedule. With Beta System,s new IAM ... and best practices gleaned from multiple IAM implementations ... includes the software as well as any necessary ...
(Date:3/10/2015)... Colo. , March 10, 2015 ... Flight "Personalized Medicine in Human Space ... and Thomas J. Goodwin , Ph.D. was recently ... of the past two years. Specifically, "Personalized ... most downloaded scientific papers published in 2013 and 2014 ...
(Date:3/3/2015)... March 3, 2015 Cryoport, Inc. ... advanced cryogenic logistics solutions for the life ... cells, cell lines, clinical research organizations, vaccine ... announced the expansion of its relationship with ... ("Fred Hutch") Clinical Research Division with the ...
Breaking Biology News(10 mins):Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2"Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3
... -- Weikang Bio-Technology Group Co., Inc. (OTC Bulletin ... "Company"), a leading developer, manufacturer and marketer of ... pharmaceuticals and other health and nutritional products in ... completion of its private placement offering for aggregate ...
... Education & Research (BTER) Foundation is pleased to announce ... for Outstanding Service in the Advancement of Biotherapy. The ... Conference on Biotherapy, held recently in Los Angeles; they ... FRCSE; Pam Mitchell; Eliot Mostow, MD, MPH; Kosta Mumcuoglu, ...
... thought that almost every plant species on the Iberian ... Taraxacum decastroi and Taraxacum lacianense , two ... range, respectively. This finding confirms Spain,s privileged position as ... new species now in Spain. It depends on the ...
Cached Biology News:Weikang Bio-Technology Announces Completion of $5.0 Million Private Placement 2Weikang Bio-Technology Announces Completion of $5.0 Million Private Placement 3BTER Foundation announces winners of the William S. Baer Award 2BTER Foundation announces winners of the William S. Baer Award 32 new plants discovered in Spain 2
... recently launched a custom synthesis service ... Thermos siRNA molecules are: Composed ... DNA bases overhang at the 3-terminus ... fully deprotected and ready-to-use. Simply ...
Mouse monoclonal [AZ24] to Polo like kinase ( Abpromise for all tested applications)....
... The dotLab System brings together ... diffraction and immobilized capture surfaces. This ... simple technique for the detection of ... of fluorescent labels. , Protein-specific capture ...
The HEPTEST assays provide a sensitive, simple, rapid, and convenient in vitro quantitation of heparin, low molecular weight heparins, and heparinoids in plasma and whole blood. Sample Type: wh...
Biology Products: